Search
for
Sort by
Research 571–600 of 1000+
- Chemical Peels: Indications and Special Considerations for the Male Patient
- Comparison of the Pathology of Fascia in Eosinophilic Myalgia Syndrome Patients and Idiopathic Eosinophilic Fasciitis
- A systematic review of dermatologic manifestations among adult patients with COVID‐19 diagnosis
- Dickkopf-1 Expression in Androgenetic Alopecia and Alopecia Areata in Male Patients
- Novel splice site mutation in the <i>LIPH</i> gene in a patient with autosomal recessive woolly hair/hypotrichosis: Case report and published work review
- Attitudes and practices of dermatologists and primary care physicians who treat patients for MPHL: results of a survey
- Cysteine and Glutamine level in hair shaft fractures patients
- Treatment Patterns and Health-Related Quality of Life in Patients with Alopecia Areata Stratified by Disease Severity in the USA
- MESOTHERAPY AS A METHOD OF CORRECTION OF ALOPESIA IN PATIENTS AFTER BARIATRY
- ANALYSIS OF ELEMENTAL COMPOSITION FROM NON-DIABETIC AND DIABETIC PATIENTS HAIRS, NAILS AND BLOOD USING SCANNING ELECTRON MICROSCOPY (SEM) AND ENERGY DISPERSIVE X-RAY SPECTROSCOPY (EDS)
- Association of Cyp11a Gene with Polycystic Ovarian Syndrome Patients in Lahore, Pakistan
- The Efficient Pre- and Post-Operative Healthcare Strategies for Sleeve Gastrectomy Patients
- A Prospective Hospital-Based Study on Cutaneous Manifestations in Patients with Polycystic Ovarian Syndrome (PCOS)
- Immune-related alopecia (areata and universalis) in cancer patients receiving immune checkpoint inhibitors
- Clinical and histopathologic features of hair loss in patients with HIV-1 infection
- New Methodology and Instrumentation for Follicular Unit Extraction: Lower Follicle Transection Rates and Expanded Patient Candidacy
- The Use of Hormonal Antiandrogen Therapy in Female Patients with Acne: A 10-Year Retrospective Study
- Raising threshold for diagnosis of polycystic ovary syndrome excludes population of patients with metabolic risk
- ASSESSMENT OF SERUM LEVELS OF ANTIGLIADIN ANTIBODIES (IgG and IgA) IN PATIENTS WITH ALOPECIA AREATA AND THEIR RELATION TO SEVERITY OF THE DISEASE
- Virilization beyond menopause: an uncommon ovarian tumor in an elderly patient with multimodality imaging and pathologic correlation
- Progressive Zinc and Iron Deficiency Following Bariatric Surgery in Iraqi Patients: A 12-Month Pilot Study
- Updated Integrated Safety Analysis of Ritlecitinib Over 72 Months In Patients With Alopecia Areata From the ALLEGRO Clinical Trial Program
- Ovarian Hilus Cell Hyperplasia and Sertoli-Leydig Cell Tumor in a Patient with Postmenopausal Virilization: a Rare Case Report
- Commentary on: An Assessment of Gender Differences in Plastic Surgery Marketing in the United States: Are We Neglecting Our Male Patients?
- Pathobiology questions raised by telogen effluvium and trichodynia in COVID‐19 patients
- Expression of COX-2 and Bcl-2 in 50 patients of Lichen Planus
- Docetaxel, cisplatin and 5-fluorouracil in patients with locally advanced unresectable head and neck cancer: a phase I–II feasibility study
- Integrated single-cell chromatin and transcriptomic analyses of peripheral immune cells in patients with alopecia areata
- Evaluation of trichodynia (hair pain) during chemotherapy or tamoxifen treatment in breast cancer patients
- Assessment of the tolerability and efficacy of supplementation containing micronized and emulsified ferric pyrophosphate in patients with iron deficiency — an observational study